Gabriele Madonna

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Squamous Cell Carcinoma

Early Breast Cancer

Prognostic Factors

Top Venues

Journal of translational medicine

International journal of molecular sciences

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, Leonardo Cristinziano, Anne Lise Ferrara, Francesco Palestra, Stefania Loffredo, Mariaelena Capone, Gabriele Madonna, Marilena Romanelli, Paolo Antonio Ascierto, Maria Rosaria Galdiero
Innate Immune Cells in Melanoma: Implications for Immunotherapy. International journal of molecular sciences 25 (15) (2024)
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, Andrea Sacconi, Mario Acunzo, Giulia Romano, Giovanni Nigita, Barbara Bellei, Gabriele Madonna, Mariaelena Capone, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto, Luigi Fattore
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors. Cell death & disease 15 (3) (2024)
Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, Leonardo Cristinziano, Anne Lise Ferrara, Francesco Palestra, Stefania Loffredo, Mariaelena Capone, Gabriele Madonna, Marilena Romanelli, Paolo Antonio Ascierto, Maria Rosaria Galdiero
Innate Immune Cells in Melanoma: Implications for Immunotherapy. International journal of molecular sciences 25 (15) (2024)
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, Andrea Sacconi, Mario Acunzo, Giulia Romano, Giovanni Nigita, Barbara Bellei, Gabriele Madonna, Mariaelena Capone, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto, Luigi Fattore
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors. Cell death & disease 15 (3) (2024)
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, Andrea Sacconi, Mario Acunzo, Giulia Romano, Giovanni Nigita, Barbara Bellei, Gabriele Madonna, Mariaelena Capone, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto, Luigi Fattore
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors. Cell death & disease 15 (3) (2024)
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino, Roberto Parrella, Vincenzo Montesarchio, Luigi Atripaldi, Paolo Antonio Ascierto, Alfredo Budillon
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer. International journal of molecular sciences 24 (5) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonello Pinto, Chrystal M Paulos, Paolo Antonio Ascierto
Potential clinical implications of CD4 + CD26 high T cells for nivolumab treated melanoma patients. Journal of translational medicine 21 (1) (2023)
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonello Pinto, Chrystal M Paulos, Paolo Antonio Ascierto
Potential clinical implications of CD4 + CD26 high T cells for nivolumab treated melanoma patients. Journal of translational medicine 21 (1) (2023)
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonello Pinto, Chrystal M Paulos, Paolo Antonio Ascierto
Potential clinical implications of CD4 + CD26 high T cells for nivolumab treated melanoma patients. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonello Pinto, Chrystal M Paulos, Paolo Antonio Ascierto
Potential clinical implications of CD4 + CD26 high T cells for nivolumab treated melanoma patients. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonello Pinto, Chrystal M Paulos, Paolo Antonio Ascierto
Potential clinical implications of CD4 + CD26 high T cells for nivolumab treated melanoma patients. Journal of translational medicine 21 (1) (2023)
Sara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, Sumadi Luckman Anwar, Chiara Casadei, Ugo De Giorgi, Gabriele Madonna, Paolo Antonio Ascierto, Rossana Verónica Mendoza López, Roger Chammas, Mariaelena Capone
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics. The oncologist (2023)
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino, Roberto Parrella, Vincenzo Montesarchio, Luigi Atripaldi, Paolo Antonio Ascierto, Alfredo Budillon
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer. International journal of molecular sciences 24 (5) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino, Roberto Parrella, Vincenzo Montesarchio, Luigi Atripaldi, Paolo Antonio Ascierto, Alfredo Budillon
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer. International journal of molecular sciences 24 (5) (2023)
Roberta Turiello, Mariaelena Capone, Elva Morretta, Maria Chiara Monti, Gabriele Madonna, Rosa Azzaro, Pasquale Del Gaudio, Ester Simeone, Antonio Sorrentino, Paolo A Ascierto, Silvana Morello
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents. Journal for immunotherapy of cancer 10 (3) (2022)
Giosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, Annabella Di Mauro, Monica Cantile, Margherita Cerrone, Gabriele Madonna, Antonio Maria Grimaldi, Domenico Mallardo, Marco Palla, Sabrina Sarno, Anna Maria Anniciello, Maurizio Di Bonito, Paolo Antonio Ascierto, Gerardo Botti
The Ratio of GrzB+ - FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma. Cancers 13 (10) (2021)
Gabriele Madonna, Silvia Sale, Mariaelena Capone, Chiara De Falco, Valentina Santocchio, Tiziana Di Matola, Giuseppe Fiorentino, Caterina Pirozzi, Anna D'Antonio, Rocco Sabatino, Lidia Atripaldi, Umberto Atripaldi, Marcello Raffone, Marcello Curvietto, Antonio Maria Grimaldi, Vito Vanella, Lucia Festino, Luigi Scarpato, Marco Palla, Michela Spatarella, Francesco Perna, Pellegrino Cerino, Gerardo Botti, Roberto Parrella, Vincenzo Montesarchio, Paolo Antonio Ascierto, Luigi Atripaldi
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression. Biology 10 (8) (2021)
Gabriele Madonna, Giuseppe V Masucci, Mariaelena Capone, Domenico Mallardo, Antonio Maria Grimaldi, Ester Simeone, Vito Vanella, Lucia Festino, Marco Palla, Luigi Scarpato, Marilena Tuffanelli, Grazia D'angelo, Lisa Villabona, Isabelle Krakowski, Hanna Eriksson, Felipe Simao, Rolf Lewensohn, Paolo Antonio Ascierto
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy. Cancers 13 (16) (2021)
Mauro Cozzolino, Stefania Cocco, Michela Piezzo, Giovanna Celia, Susan Costantini, Valentina Abate, Francesca Capone, Daniela Barberio, Laura Girelli, Elisa Cavicchiolo, Paolo Antonio Ascierto, Gabriele Madonna, Alfredo Budillon, Michelino De Laurentiis
A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results. Journal of clinical medicine 10 (1) (2021)
Valentina Borzillo, Rossella Di Franco, Diana Giannarelli, Fabrizio Cammarota, Esmeralda Scipilliti, Emma D'Ippolito, Angela Petito, Marcello Serra, Sara Falivene, Antonio M Grimaldi, Ester Simeone, Lucia Festino, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Gabriele Madonna, Paolo Antonio Ascierto, Paolo Muto
Ipilimumab and Stereotactic Radiosurgery with CyberKnife® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience. Cancers 13 (8) (2021)
Michele Guida, Bartolomeo Nicola, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, Anna M Di Giacomo, Alessandro M Minisini, Marco Tucci, Francesco Spagnolo, Marcella Occelli, Laura Ridolfi, Paola Queirolo, Ivana De Risi, Davide Quaresmini, Elisabetta Gambale, Vanna Chiarion Sileni, Paolo Antonio Ascierto, Lucia Stigliano, Sabino Strippoli, null On Behalf Of The Italian Melanoma Intergroup Imi Study
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. Cancers 13 (3) (2021)
Luigi Scarpato, Lucia Festino, Vito Vanella, Gabriele Madonna, Massimo Mastroianni, Marco Palla, Paolo Antonio Ascierto
Dermatologic adverse events associated with targeted therapies for melanoma. Expert opinion on drug safety (2021)
Anna Barbato, Antonella Iuliano, Mariagrazia Volpe, Romina D'Alterio, Simona Brillante, Filomena Massa, Rossella De Cegli, Sabrina Carrella, Massimiliano Salati, Annapina Russo, Giulia Russo, Sara Riccardo, Davide Cacchiarelli, Mariaelena Capone, Gabriele Madonna, Paolo A Ascierto, Brunella Franco, Alessia Indrieri, Pietro Carotenuto
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma. International journal of molecular sciences 22 (4) (2021)
Sergio Marlino, Barbara Cagli, Andrea Vitale, Andrea Boccia, Stefano Avvedimento, Gabriele Madonna, Adriano Santorelli
Bleeding in Plastic-Aesthetic Surgery: A Prognostic Pathway with Clinical Application. Aesthetic plastic surgery 44 (1) (2019)